Turning Point Brands saw a 29.2% increase in net sales for Q4 2025, driven by the explosive growth of its Modern Oral products within the Stoker's segment. While the Zig-Zag segment faced headwinds from the Clipper business wind-down, the company achieved strong adjusted EBITDA growth and maintained a robust liquidity position.
Modern Oral net sales surged 266% to $41.3 million, now representing 34% of total company sales.
Stoker's segment net sales grew 69.5% to $81.0 million, fueled by triple-digit Modern Oral growth.
Zig-Zag segment net sales declined 12.8% due to the planned wind-down of the Clipper business.
Net income attributable to the company increased 239.8% to $8.2 million compared to the prior year period.
The company provided a positive outlook for 2026, specifically targeting significant growth in the Modern Oral category while managing investments in brand building.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance